Clinical trial
Efficacy and Safety Study of Novel Spectacle Lens Designs to Control of Myopia
NCT03623074 is registered in ClinicalTrials.gov with SightGlass Vision, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety Study of Novel Spectacle Lens Designs to Control of Myopia
- Lead sponsor
- SightGlass Vision, Inc.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 16, 2018
- Completion date
- December 31, 2026
- Enrollment
- 266 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
juvenile myopia